Orchard Therapeutics plc
Orchard Therapeutics plc (ORTX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ORTX · as of Jun 30, 2023
Ownership Breakdown
1
Institutional Holders
▲ 1 vs Q1
$10.64M
Total Inst. Value
▲ $10.64M vs Q1
22.76M
Shares Outstanding
freeFloat 516.27%
2.04M
13F Shares Held
▲ 2.04M vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ORTX largest shareholders · institutional ownership
Q2 2023 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
DEEP TRACK CAPITAL, LP biological products, (no diagnostic substances) | 2.04M | 10.79% | 10.79% | $10.64B | Sep 6, 2023 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2023 vs prior quarter
Q2 2023
0
Increased
+0 shares1
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+1
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ORTX insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
29
Sell transactions
0.00
Buy/Sell ratio
$5M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Secor Alicia director | Jan 24, 2024 | D-Return | 46,000 | $0.47 | $21.9K | 0 | Form 4 ↗ |
Secor Alicia director | Jan 24, 2024 | D-Return | 105,000 | $0.49 | $52.0K | 0 | Form 4 ↗ |
GERAGHTY JAMES A director | Jan 24, 2024 | D-Return | 46,000 | $0.47 | $21.9K | 0 | Form 4 ↗ |
GERAGHTY JAMES A director | Jan 24, 2024 | D-Return | 105,000 | $0.49 | $52.0K | 0 | Form 4 ↗ |
GERAGHTY JAMES A director | Jan 24, 2024 | D-Return | 44,391 | $16.00 | $710.3K | 0 | Form 4 ↗ |
THOMAS FRANK E See Remarks | Jan 24, 2024 | D-Return | 335,000 | $0.46 | $153.8K | 0 | Form 4 ↗ |
THOMAS FRANK E See Remarks | Jan 24, 2024 | D-Return | 405,590 | $0.46 | $188.2K | 0 | Form 4 ↗ |
THOMAS FRANK E See Remarks | Jan 24, 2024 | D-Return | 179,390 | $0.58 | $104.0K | 0 | Form 4 ↗ |
THOMAS FRANK E See Remarks | Jan 24, 2024 | D-Return | 92,081 | $16.00 | $1.47M | 0 | Form 4 ↗ |
Rowland Charles A Jr director | Jan 24, 2024 | D-Return | 46,000 | $0.47 | $21.9K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Orchard Therapeutics plc (ORTX) is primarily owned by institutional investors, who hold approximately 9.0% of total shares outstanding. Company insiders own approximately 0.00%, while retail and public investors account for the remaining 507.30%.
The largest institutional shareholder of Orchard Therapeutics plc is DEEP TRACK CAPITAL, LP, holding approximately 2.04 million shares — equal to 10.79% of outstanding shares — as of June 30, 2023.
A total of 1 institutional investors currently hold ORTX stock, with a combined institutional value of approximately $10,637,101 as of the most recent 13F filing period.
Frequently asked questions
ORTX ownershipOrchard Therapeutics plc (ORTX) is primarily owned by institutional investors, who hold approximately 9.0% of shares. The largest shareholder is DEEP TRACK CAPITAL, LP with a 10.79% stake. Company insiders hold 0.00%. Data sourced from SEC Form 13F as of June 30, 2023.